– GEN’s Editor-in-Chief John Sterling interviews Kenneth Carter, Ph.D., President and CEO, Avalon Pharmaceuticals

Previous articleStudy Refutes Theory of How Adult Stem Cells Segregate DNA
Next articleScientists Elucidate Pathway for Lymphoma Growth